MERIDIAN BIOSCIENCE, INC. Net Change in Cash
MERIDIAN BIOSCIENCE, INC. reported Net Change in Cash of -$7.36 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-02-09
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-12-31 was -$7.36M, a 132.04% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-12-31 was $22.96M, a 137.19% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-12-31 was $9.68M, a 57.13% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-12-31 was $6.16M, a 250.00% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $31.68M.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$3.74M.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$8.88M, a 643.64% decline from fiscal 2019.
- MERIDIAN BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $1.63M, a 39.28% decline from fiscal 2018.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$7.36M 10-Q · filed 2023-02-09 | |||
| 2022-09-30 | $31.68M 10-K · filed 2022-11-22 | |||
| 2022-06-30 | $33.72M 10-Q · filed 2022-08-05 | |||
| 2022-03-31 | $26.72M 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | $22.96M 10-Q · filed 2023-02-09 | |||
| 2021-09-30 | -$3.74M 10-K · filed 2022-11-22 | |||
| 2021-06-30 | $16.50M 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | $9.86M 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $9.68M 10-Q · filed 2022-02-04 | |||
| 2020-09-30 | -$8.88M 10-K · filed 2022-11-22 | |||
| 2020-06-30 | $1.05M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$12.85M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $6.16M 10-Q · filed 2021-02-05 | |||
| 2019-09-30 | $1.63M 10-K · filed 2021-11-23 | |||
| 2019-06-30 | -$5.57M 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $6.33M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $1.76M 10-Q · filed 2020-02-07 | |||
| 2018-09-30 | $2.69M 10-K · filed 2020-11-23 | |||
| 2018-06-30 | $858.00K 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | -$672.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$2.36M 10-Q · filed 2019-02-11 | |||
| 2017-09-30 | $9.85M 10-K · filed 2019-11-26 |